Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Biotech
Biotech
HHS preps for pandemics, doles out $55M to Vir for flu mAb
HHS has granted Vir Biotechnology a multiyear contract and the chance to make up to $1 billion in efforts to prepare for public health emergencies.
Gabrielle Masson
Oct 4, 2022 3:05pm
Biohaven veers toward Kv7 platform following Pfizer sale
Oct 4, 2022 11:48am
BMS inks 2nd biotech deal in one day, this time with Autolus
Oct 4, 2022 10:50am
KalVista axes angioedema program over raised enzyme levels
Oct 4, 2022 10:32am
Fierce Biotech Fundraising Tracker: Cellarity, Alloy and more
Oct 4, 2022 10:00am
Pfizer pulls trigger on Voyager gene therapy capsid deal
Oct 4, 2022 9:46am
